Home > Financial Ratios > JENBURKT PHARMACEUTICALS

JENBURKT PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
JENBURKT PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for JENBURKT PHARMACEUTICALS
Please provide your vote to see the results

JENBURKT PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 24.696.4710.2133.350.78

What is the latest Core EBITDA Growth ratio of JENBURKT PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of JENBURKT PHARMACEUTICALS is 24.69 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar202524.69
Mar20246.47
Mar202310.21
Mar202233.35
Mar20210.78

How is Core EBITDA Growth of JENBURKT PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 24.69
281.61
Mar2024 6.47
-36.63
Mar2023 10.21
-69.39
Mar2022 33.35
4,175.64
Mar2021 0.78 -

Other Financial Ratios of JENBURKT PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of JENBURKT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JENBURKT PHARMACEUTICALS ₹582.1 Cr 0.1% 0.4% 53.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,551.0 Cr 0.4% 1.8% 4.5% Stock Analytics
DIVIS LABORATORIES ₹175,704.0 Cr -1.1% 0.1% 45.6% Stock Analytics
CIPLA ₹123,675.0 Cr 3.8% 1.2% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,925.0 Cr 2.2% 11.7% 11.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,626.0 Cr 1.4% -3.3% -7.2% Stock Analytics


JENBURKT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JENBURKT PHARMACEUTICALS

0.1%

0.4%

53.9%

SENSEX

-0.4%

-1.6%

1.3%


You may also like the below Video Courses